Literature DB >> 30623522

Prevalence and evolution of spasticity in patients suffering from first-ever stroke with carotid origin: a prospective, longitudinal study.

T Dorňák1, M Justanová2, R Konvalinková3, M Říha4, J Mužík5, M Hoskovcová3, M Srp3, D Navrátilová1, P Otruba1, O Gál3, I Svobodová5, L Dušek5, M Bareš2,6, P Kaňovský1, R Jech3.   

Abstract

BACKGROUND AND
PURPOSE: The main aim of the study was to document the occurrence and evolution of post-stroke spasticity (PSS). The secondary goal was to identify predictors for increases and decreases in PSS rates during 12 months of subsequent follow-up.
METHODS: In a longitudinal, multicenter, prospective cohort study, assessments were done at 7 days (V1), 6 months (V2), and 12 months (V3) after stroke onset. A total of 307 consecutive patients from four comprehensive stroke centers with the first-ever stroke of carotid origin and the presence of motor deficit at day 7 were included. The demographic data, baseline characteristics, Barthel index, degree and pattern of paresis and muscle tone were evaluated and recorded. Spasticity was assessed using the modified Ashworth scale.
RESULTS: Spasticity was present in 45.0% of patients at V1, in 49.5% at V2, and in 43.2% at V3. A significant number of patients experienced changes in spasticity between visits: increased/new occurrence of spasticity in 32.5% (V1 and V2) and in 13.6% (V2 and V3) of patients; decreased occurrence/disappearance of spasticity in 18.5% (V1 and V2) and in 18.3% (V2 and V3) of patients. The number of patients with severe spasticity increased throughout the year, from 2.6% to 13.0% (V2) and 12.5% (V3).
CONCLUSIONS: Spasticity developed in almost half of the included patients. The degree of spasticity often changed over time, in both directions. The rate of severe spasticity increased during the first year, with the maximum at 6 months following stroke onset.
© 2019 EAN.

Entities:  

Keywords:  carotid artery; incidence; prevalence; spasticity; stroke

Mesh:

Year:  2019        PMID: 30623522     DOI: 10.1111/ene.13902

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  7 in total

1.  Prevalence and Risk Factors for Spasticity After Stroke: A Systematic Review and Meta-Analysis.

Authors:  Huangling Zeng; Jian Chen; Yang Guo; Sheng Tan
Journal:  Front Neurol       Date:  2021-01-20       Impact factor: 4.003

Review 2.  The Central Effects of Botulinum Toxin in Dystonia and Spasticity.

Authors:  Pavel Hok; Tomáš Veverka; Petr Hluštík; Martin Nevrlý; Petr Kaňovský
Journal:  Toxins (Basel)       Date:  2021-02-17       Impact factor: 4.546

3.  Role of Spasticity Severity in the Balance of Post-stroke Patients.

Authors:  Ashraf Mahmoudzadeh; Noureddin Nakhostin Ansari; Soofia Naghdi; Ehsan Ghasemi; Omid Motamedzadeh; Brandon S Shaw; Ina Shaw
Journal:  Front Hum Neurosci       Date:  2021-12-10       Impact factor: 3.169

4.  Reliability and diagnostic accuracy of corrected slack angle derived from 2D-SWE in quantitating muscle spasticity of stroke patients.

Authors:  Junyan Cao; Yang Xiao; Weihong Qiu; Yanling Zhang; Zulin Dou; Jie Ren; Rongqin Zheng; Hairong Zheng; Zhaocong Chen
Journal:  J Neuroeng Rehabil       Date:  2022-02-05       Impact factor: 4.262

5.  Comprehensive Assessment of the Time Course of Biomechanical, Electrophysiological and Neuro-Motor Effects after Botulinum Toxin Injections in Elbow Flexors of Chronic Stroke Survivors with Spastic Hemiplegia: A Cross Sectional Observation Study.

Authors:  Yen-Ting Chen; Yang Liu; Chuan Zhang; Elaine Magat; Ping Zhou; Yingchun Zhang; Sheng Li
Journal:  Toxins (Basel)       Date:  2022-01-28       Impact factor: 4.546

6.  Early Use of Phenol Neurolysis Likely Reduces the Total Amount of Botulinum Toxin in Management of Post-Stroke Spasticity.

Authors:  Sheng Li; Jean Woo; Manuel F Mas
Journal:  Front Rehabil Sci       Date:  2021-09-16

7.  Validation of the Spanish Version of Newcastle Stroke-Specific Quality of Life Measure (NEWSQOL).

Authors:  Concepción Soto-Vidal; Soraya Pacheco-da-Costa; Victoria Calvo-Fuente; Sara Fernández-Guinea; Carlos González-Alted; Tomás Gallego-Izquierdo
Journal:  Int J Environ Res Public Health       Date:  2020-06-14       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.